ArticleMolecular cancer research : MCR2022

Attenuating Adaptive VEGF-A and IL8 Signaling Restores Durable Tumor Control in AR Antagonist-Treated Prostate Cancers.

Pamela J Maxwell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.